Additionally, our data showed that decreased expression of TET1 was associated with poorer prognosis of CCA patients with chemotherapy, and the level of TET1 expression has a potential value for the prediction of clinical outcomes in CCA patients with chemotherapy. The gene discussed is TET1; the disease is cholangiocarcinoma.